Literature DB >> 15362203

Effects of pH management during deep hypothermic bypass on cerebral oxygenation: alpha-stat versus pH-stat.

Zhi-jun Li1, Xiao-mei Yin, Jian Ye.   

Abstract

OBJECTIVE: There is a remarkable lack of scientific evidence to support the option to use alpha-stat or pH-stat management, as to which is more beneficial to brain protection during deep hypothermic CPB. This study examined cortical blood flow (CBF), cerebral oxygenation, and brain oxygen consumption in relation to deep hypothermic CPB with alpha-stat or pH-stat management.
METHODS: Twenty-two pigs were cooled with alpha-stat or pH-stat during CPB to 15 degrees C esophageal temperature. CBF and cerebral oxygenation were measured continuously with a laser flowmeter and near-infrared spectroscopy, respectively. Brain oxygen consumption was measured with standard laboratory techniques.
RESULTS: During CPB cooling, CBF was significantly decreased, about 52.2%+/-6.3% (P<0.01 vs 92.6%+/-6.5% of pH-stat) at 15 degrees C in alpha-stat, whereas there were no significant changes in CBF in pH-stat. While cooling down, brain oxygen extraction (OER) progressively decreased, about 9.5%+/-0.9% and 10.9%+/-1.5% at 15 degrees C in alpha-stat and pH-stat, respectively. At 31 degrees C the decreased value in pH-stat was lower than in alpha-stat (29.9%+/-2.7% vs 22.5%+/-1.9%; P<0.05). The ratio of CBF/OER were 2.0+/-0.3 in alpha-stat and pH-stat, respectively; it was kept in constant level in alpha-stat, and significantly increased by 19 degrees C to 15 degrees C in pH-stat (4.9+/-0.9 vs 2.3+/-0.4; P<0.01). In mild hypothermia, cerebral oxyhemoglobin and oxygen saturation in alpha-stat were greater than that in pH-stat (102.5%+/-1.4% vs 99.1%+/-0.7%; P<0.05). In deep hypothermia, brain oxygen saturation in pH-stat was greater than that in alpha-stat (99.2%+/-1.0% vs 93.8%+/-1.0%; P<0.01), and deoxyhemoglobin in pH-stat decreased more greatly than that in alpha-stat (28.7%+/-6.8% vs 54.1%+/-4.7%; P<0.05).
CONCLUSIONS: In mild hypothermic CPB, brain tissue oxygen saturation was greater in alpha-stat than in pH-stat. However, cerebral oxygenation and brain tissue oxygen saturation were better in pH-stat than in alpha-stat during profound hypothermia. PH-stat strategy provided much more oxygen to brain tissue before deep hypothermic circulatory arrest.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15362203      PMCID: PMC1388736          DOI: 10.1631/jzus.2004.1290

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci        ISSN: 1009-3095


  11 in total

1.  Temperature conditions and oxygen consumption during deep hypothermia.

Authors:  L A CIVALERO; J R MORENO; A SENNING
Journal:  Acta Chir Scand       Date:  1962-03

2.  The brain uses mostly dissolved oxygen during profoundly hypothermic cardiopulmonary bypass.

Authors:  F Dexter; F H Kern; B J Hindman; W J Greeley
Journal:  Ann Thorac Surg       Date:  1997-06       Impact factor: 4.330

Review 3.  Cytochrome c oxidase: understanding nature's design of a proton pump.

Authors:  S I Chan; P M Li
Journal:  Biochemistry       Date:  1990-01-09       Impact factor: 3.162

4.  Monitoring regional cerebral oxygen saturation using near-infrared spectroscopy during pulsatile hypothermic cardiopulmonary bypass in a neonatal piglet model.

Authors:  A Undar; H C Eichstaedt; O H Frazier; C D Fraser
Journal:  ASAIO J       Date:  2000 Jan-Feb       Impact factor: 2.872

5.  Cerebral oxygenation during cardiopulmonary bypass measured by near-infrared spectroscopy: effects of hemodilution, temperature, and flow.

Authors:  A Lassnigg; M Hiesmayr; P Keznickl; T Müllner; M Ehrlich; G Grubhofer
Journal:  J Cardiothorac Vasc Anesth       Date:  1999-10       Impact factor: 2.628

6.  Perioperative effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants.

Authors:  A J du Plessis; R A Jonas; D Wypij; P R Hickey; J Riviello; D L Wessel; S J Roth; F A Burrows; G Walter; D M Farrell; A Z Walsh; C A Plumb; P del Nido; R P Burke; A R Castaneda; J E Mayer; J W Newburger
Journal:  J Thorac Cardiovasc Surg       Date:  1997-12       Impact factor: 5.209

7.  The effect of temperature management during cardiopulmonary bypass on neurologic and neuropsychologic outcomes in patients undergoing coronary revascularization.

Authors:  C T Mora; M B Henson; W S Weintraub; J M Murkin; T D Martin; J M Craver; J P Gott; R A Guyton
Journal:  J Thorac Cardiovasc Surg       Date:  1996-08       Impact factor: 5.209

8.  Comparison of neurologic outcome after deep hypothermic circulatory arrest with alpha-stat and pH-stat cardiopulmonary bypass in newborn pigs.

Authors:  M A Priestley; J A Golden; I B O'Hara; J McCann; C D Kurth
Journal:  J Thorac Cardiovasc Surg       Date:  2001-02       Impact factor: 5.209

Review 9.  Cerebral blood flow and metabolism during cardiopulmonary bypass.

Authors:  R M Schell; F H Kern; W J Greeley; S R Schulman; P E Frasco; N D Croughwell; M Newman; J G Reves
Journal:  Anesth Analg       Date:  1993-04       Impact factor: 5.108

10.  Stroke following coronary artery bypass grafting: a ten-year study.

Authors:  T J Gardner; P J Horneffer; T A Manolio; T A Pearson; V L Gott; W A Baumgartner; A M Borkon; L Watkins; B A Reitz
Journal:  Ann Thorac Surg       Date:  1985-12       Impact factor: 4.330

View more
  2 in total

1.  Hypocarbia and adverse outcome in neonatal hypoxic-ischemic encephalopathy.

Authors:  Athina Pappas; Seetha Shankaran; Abbot R Laptook; John C Langer; Rebecca Bara; Richard A Ehrenkranz; Ronald N Goldberg; Abhik Das; Rosemary D Higgins; Jon E Tyson; Michele C Walsh
Journal:  J Pediatr       Date:  2010-12-10       Impact factor: 4.406

2.  Effect of deep hypothermic circulatory arrest followed by low-flow cardiopulmonary bypass on brain metabolism in newborn piglets: comparison of pH-stat and α-stat management.

Authors:  Afsaneh Pirzadeh; Gregory Schears; Peter Pastuszko; Huiping Liu; Joanna Kubin; Erin Reade; Alberto Mendoza-Paredes; William Greeley; Vinay Nadkarni; David F Wilson; Anna Pastuszko
Journal:  Pediatr Crit Care Med       Date:  2011-03       Impact factor: 3.624

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.